Edgewell Personal Care Co key statistics and ratios
In fiscal 2025, Edgewell Personal Care Co had return on equity of 1.6%, an operating margin of 4.3%, debt equal to 89.5% of equity and a current ratio of 1.76. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Sept 2009 | 2010Sept 2010 | 2011Sept 2011 | 2012Sept 2012 | 2013Sept 2013 | 2014Sept 2014 | 2015Sept 2015 | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 46.5% | 47.5% | 46.2% | 46.8% | 49.0% | 49.4% | 48.9% | 49.1% | 49.0% | 46.2% | 45.1% | 45.2% | 45.6% | 40.5% | 41.8% | 42.4% | 41.6% | 39.5% |
| Operating margin | — | — | — | — | — | — | — | — | — | — | 11.4% | 9.0% | 11.5% | 8.4% | 10.1% | 8.8% | 4.3% | 0.8% |
| Net margin | 7.4% | 9.5% | 5.6% | 9.0% | 16.6% | 13.6% | −11.4% | 7.6% | 0.2% | 4.6% | −17.4% | 3.5% | 5.6% | 4.6% | 5.1% | 4.4% | 1.1% | −4.2% |
| Free-cash-flow margin | 8.7% | 12.8% | 6.8% | 11.4% | 26.9% | 18.6% | 2.0% | 5.0% | 10.6% | 8.8% | 6.2% | 9.5% | 8.2% | 2.1% | −11.8% | −12.8% | 1.9% | 2.3% |
| Return on equity | 16.9% | 20.9% | 12.4% | 19.6% | 18.0% | 14.3% | −12.6% | 9.7% | 0.3% | 5.9% | −24.4% | 4.9% | 7.8% | 6.5% | 7.6% | 6.3% | 1.6% | −6.2% |
| Return on assets | 4.8% | 6.4% | 4.0% | 6.2% | 6.1% | 5.2% | −4.6% | 3.7% | 0.1% | 2.5% | −10.1% | 1.9% | 3.3% | 2.7% | 3.1% | 2.6% | 0.7% | −2.6% |
| Asset turnover | 0.65 | 0.68 | 0.72 | 0.69 | 0.36 | 0.38 | 0.41 | 0.48 | 0.51 | 0.55 | 0.58 | 0.56 | 0.58 | 0.59 | 0.60 | 0.60 | 0.59 | 0.62 |
| Current ratio | 1.83 | 1.94 | 2.20 | 1.93 | 2.23 | 1.73 | 2.45 | 1.67 | 2.26 | 1.33 | 1.58 | 1.93 | 2.12 | 1.75 | 1.84 | 1.66 | 1.76 | 1.84 |
| Debt to equity | 135.6% | 109.0% | 112.7% | 122.4% | 91.2% | 90.7% | 92.4% | 99.8% | 87.6% | 74.1% | 93.4% | 86.9% | 78.6% | 95.8% | 89.1% | 81.1% | 89.5% | 85.6% |
| Interest cover (operating income ÷ interest) | — | — | — | — | — | — | — | — | — | — | 3.9x | 2.9x | 3.5x | 2.6x | 2.9x | 2.6x | 1.3x | 0.3x |
| Effective tax rate | 33.1% | 25.8% | 35.7% | 27.7% | 24.4% | 19.3% | — | 18.7% | — | 36.9% | — | 22.6% | 19.9% | 19.8% | 22.3% | 18.4% | −7.6% | — |
| R&D as % of revenue | 2.3% | 2.3% | 2.3% | 2.5% | 2.8% | 2.7% | 2.9% | 3.0% | 2.9% | 2.7% | 2.5% | 2.8% | 2.8% | 2.6% | 2.6% | 2.6% | 2.6% | 2.6% |
| SG&A as % of revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 18.2% | 19.1% | 19.1% | 19.8% |
| Capital spending as % of revenue | 3.5% | 2.6% | 2.1% | 2.4% | 3.7% | 3.3% | 4.1% | 2.9% | 3.0% | 2.8% | 2.7% | 2.4% | 2.7% | 2.6% | 2.2% | 2.5% | 3.5% | 3.1% |
| Free cash flow ÷ net income | 117.4% | 134.9% | 120.4% | 127.3% | 162.0% | 136.7% | — | 65.6% | >999% | 191.1% | — | 273.5% | 146.2% | 45.8% | −231.6% | −291.6% | 163.0% | — |
| Dividends ÷ net income | — | 0.0% | 0.0% | 6.1% | 25.9% | 34.8% | — | 0.0% | 0.0% | — | — | 0.0% | 21.7% | 32.8% | 27.5% | 31.1% | 115.4% | — |
| Dividends and buybacks ÷ free cash flow | 0.0% | 0.0% | 87.8% | 85.0% | 16.0% | 44.9% | 543.3% | 167.6% | 67.6% | 63.0% | 0.0% | 0.0% | 20.2% | 346.3% | — | — | 288.6% | 84.4% |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Dec 2024 | 2025 Q2Mar 2025 | 2025 Q3Jun 2025 | 2025 Q4Sept 2025 | 2026 Q1Dec 2025 | 2026 Q2Mar 2026 | 2026 Q3Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 41.1% | 41.6% | 45.9% | 44.6% | 36.3% | 38.1% | 41.8% | 42.5% |
| Operating margin | 3.9% | 2.2% | 9.5% | 8.0% | −0.9% | −4.5% | 3.5% | 4.4% |
| Net margin | 1.7% | −0.5% | 5.6% | 5.2% | −4.2% | −15.5% | −2.0% | 2.4% |
| Free-cash-flow margin | −80.0% | −31.9% | 5.4% | 17.7% | 6.4% | −32.5% | 7.8% | 18.1% |
| Current ratio | 1.66 | 2.06 | 1.89 | 1.77 | 1.76 | 2.12 | 1.81 | 1.84 |
| Debt to equity | 80.5% | 96.0% | 94.7% | 87.5% | 89.1% | 102.3% | 85.9% | 85.3% |
| R&D as % of revenue | 3.1% | 3.2% | 2.6% | 2.4% | 2.4% | 3.3% | 2.9% | 2.3% |
| SG&A as % of revenue | 21.1% | 24.0% | 19.9% | 18.0% | 16.7% | 24.2% | 21.4% | 19.0% |
Financial health
- Short-term assets cover short-term liabilities $1.1bn of assets due within a year against $604m of liabilities due within a year.
- Short-term assets cover long-term liabilities $1.1bn short-term assets against $1.5bn of longer-dated liabilities.
- More cash than debt $397m of cash against $1.2bn of debt.
- Debt below 40% of shareholders' equity Debt is 85% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 92% to 85% over five years.
- A year's operating cash flow covers at least 20% of debt $121m of operating cash flow against $1.2bn of debt.
- Operating profit covers interest at least five times over Operating income of $18m against $69m of interest.
Moat
Weak moat
How hard Edgewell Personal Care's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 1 / 20
Net income has been a median 2.5% of total assets over 10 years.
- Pricing power 14 / 20
Gross margin has been a median 44.0%, moving by 2.9 percentage points (standard deviation) across 10 years.
- Durability 3 / 20
Operating margin has been a median 9.4%; its worst year was 0.8%.
- Cash conversion 11 / 20
Free cash flow was positive in 8 of 10 years, at a median 6.0% of revenue.
- Discipline 20 / 20
The diluted share count fell 15.2% over five years; stock-based pay has been a median 1.0% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (49 before it).
Compare with peers
- Bellring Brands, Inc. statistics
- E.l.f. Beauty, Inc. statistics
- Interparfums Inc statistics
- NU Skin Enterprises, Inc. statistics
- Herbalife LTD. statistics
Head to head: BRBR vs EPCELF vs EPCEPC vs IPAREPC vs HLF
More: Personal Care Products stocks compared, Consumer Staples sector, rankings of US companies